A display contains frozen items, and the shelves are stocked with jars and cans. But there’s just one reason to visit this Boerum Hill business: meat.
NYS Entity Status
NYS Filing Date
JANUARY 07, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - HAR'D LIFE INK CORP.
AROUND THE WEB
- Neighborhood Joint: Staubitz Market in Brooklyn: 100 Years of Sawdust, Steaks and Chops
By ANDREW COTTO - Wednesday Jun 14, 2017
- When You Can’t Afford to Be a Bridesmaid
By Holly Johnson - Monday Jun 5, 2017
Several years ago, Sylvia Inks was caught in an uncomfortable dilemma. A childhood friend asked her to be the maid of honor at her wedding, but Inks doubted whether she could – or even should – participate. Just two years out of college herself, Inks felt the marriage was rushed and a bad idea. Her friend’s fiancé had broken up with her at least three times the year before. Plus, something about their relationship just didn’t seem right. But digging deeper, Inks ...
- Cyclist Killed by Bus in New York’s First Citi Bike Fatality
By MATTHEW HAAG and HANNAH ALANI - Tuesday Jun 13, 2017
Dan Hanegby of Brooklyn fell under a bus’s tires in Chelsea. He worked for Credit Suisse and was once the top-ranked tennis player in Israel.
- Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
By LIAM STACK - Monday Jun 19, 2017
The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.
- Living the Urban Life Upstate
By KIM VELSEY - Friday Jun 16, 2017
A New York couple who prefer to rent in the thick of things, even in a Hudson Valley town.
- 'NY Times' Finally Joins Snapchat Discover
Monday Apr 24, 2017
Does The New York Times joining Snapchat Discover lend an air of respectability to a new platform, and breathe new life into an aging publisher? That's obviously what the partners are planning -- butonly time will tell.
- Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
By Frank Vinluan - Tuesday May 30, 2017
Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]